准确可靠:试剂盒原料经过验证,批间一致性高,保证实验结果稳定可靠,更有利于长期开发优化验证实验。
快速高效:通过使用生物素标记蛋白,减少标记过程,省时省力;方法充分验证,节省方法建立及验证时间。
降低干扰:基质干扰小,验证DMSO对体系造成的干扰,确保可以用来筛选小分子及大分子抑制剂。
高重复性:生物素标记蛋白采用定点标记,更稳定的标记方法保证了批间一致性及试剂盒的稳定性。
| 规格 | 96 Tests | |
| 检测方法 | 显色法 | |
| 方法类型 | 竞争ELISA | |
| 应用 | 高通量筛选抗体、小分子抑制剂、多肽等。 | |
| ID | Components | Size |
|---|---|---|
| EP101-C01 | High-bind Plate | 1 plate |
| EP101-C02 | Human PD-L1 | 25 μg |
| EP101-C03 | Anti-PD-1 Neutralizing Antibody | 20 μg |
| EP101-C04 | Human PD-1-Biotin | 5 μg |
| EP101-C05 | Streptavidin-HRP | 10 μg |
| EP101-C06 | Coating Buffer | 12 mL |
| EP101-C07 | 10xWashing Buffer | 50 mL |
| EP101-C08 | Blocking Buffer | 50 mL |
| EP101-C09 | Substrate Solution | 12 mL |
| EP101-C10 | Stop Solution | 7 mL |
使用PD-1 [Biotinylated] : PD-L1 抑制剂筛选试剂盒(Cat. No. EP-101)来检测抗PD-1中和抗体对PD-1: PD-L1结合的抑制效果
Anti-PD-1 neutralizing antibody was diluted from 10 μg/mL to 0.078 μg/ mL (69.628 nM to 0.544 nM) and loaded onto the plate coated by human PD-L1 in the presence of human PD-1-Biotin. Assay was performed according to the protocol in PD-1[Biotinylated] : PD-L1 Inhibitor Screening ELISA Assay Pair. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).
申请 Protocol
使用CD47: SIRP alpha [biotinylated]抑制剂筛选试剂盒(Cat. No. EP-102)来检测抗CD47中和性抗体对CD47: SIRP alpha结合的抑制效果
Serial dilutions of anti-CD47 neutralizing antibody (Catalog # CD7-NA002) (1:2 serial dilutions, from 10 μg/mL to 0.04 μg/mL or 66.67 nM to 0.26 nM) was added into CD47: biotinylated SIRP alpha binding reactions. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).
申请 Protocol
使用IL-4 [biotinylated]: IL-4 R alpha抑制剂筛选试剂盒(Cat. No. EP-132) 来检测Human IL-4对IL-4: IL-4 R alpha结合的抑制效果
Serial dilutions of Human IL-4(Catalog # EP132-C03) (1:1 serial dilution, from 5 μg/mL to 0.01 μg/mL (295.86-0.58 nM)) was added into IL-4 R alpha: IL-4-Biotin binding reactions. The assay was performed according to the above-described protocol. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).
申请 Protocol
使用Integrin α 4 β 7: MAdCAM-1 [Biotinylated]抑制剂筛选试剂盒(Cat. No. EP-155) 检测抗Integrin α 4 β 7中和抗体对Integrin α 4 β 7: MAdCAM-1结合的抑制效果
Serial dilutions of Anti-Integrin α 4 β 7 Neutralizing antibody (Catalog # EP155-C04) (1:1 serial dilution, from 5 μg/mL to 0.0098μg/mL) was added into Integrin α 4 β 7: Biotinylated MAdCAM-1 binding reactions. The assay was performed according to the protocol described below. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).
申请 Protocol